Concepedia

Jeffrey T. Bagdanoff

JT

Statistics

Publications

16

Citations

955

H-Index

14

Active since

1998

Affiliations

California Institute of Technology(Current)

Novartis (Switzerland)

Novartis (United States)

Lexicon Pharmaceuticals (United States)

Jeffrey T. Bagdanoff is an author at California Institute of Technology specializing in drug discovery, pharmacology, and medicinal chemistry.

Top concepts

PharmacologyDrug DiscoveryMedicineMedicinal ChemistryChemistryEngineeringNatural SciencesOrganic ChemistryChemical EngineeringCatalysis

Publications per year

1998–2023

16

Publications

16

Pd-Catalyzed Enantioselective Aerobic Oxidation of Secondary Alcohols: Applications to the Total Synthesis of Alkaloids

Shyam Krishnan, Jeffrey T. Bagdanoff, David C. Ebner et al. · Journal of the American Chemical Society · 2008 · 157 citations · Full text

Palladium-Catalyzed Enantioselective Oxidation of Alcohols: A Dramatic Rate Acceleration by Cs<sub>2</sub>CO<sub>3</sub>/<i>t</i>-BuOH

Jeffrey T. Bagdanoff, Brian M. Stoltz · Organic Letters · 2003 · 103 citations

Palladium‐Catalyzed Oxidative Kinetic Resolution with Ambient Air as the Stoichiometric Oxidation Gas

Jeffrey T. Bagdanoff, Brian M. Stoltz · Angewandte Chemie International Edition · 2003 · 94 citations

Engineering, Organic Chemistry, Nonflammable Solvents +16

6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

Medicinal Chemistry, Allosteric Shp2 Inhibitors, Drug Target +15

Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors

Jeffrey T. Bagdanoff, Zhouliang Chen, Michael Acker et al. · Journal of Medicinal Chemistry · 2019 · 79 citations · Full text

Medicinal Chemistry, Signaling Pathway, Receptor Tyrosine Kinase +16

1–5 of 16